Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, February 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 22 X users
googleplus: 1 Google+ user

Readers on

mendeley: 167 Mendeley

Summary News Blogs Policy documents X Google+

So far, Altmetric has seen 3 news stories from 3 outlets.

News story from EX BULLETIN on Friday 08 September 2023

EX BULLETIN, 08 Sep 2023

Alzheimer Prevention: The Skinny on Genes and Fats

UBM Medica, 01 May 2017

RESEARCH UPDATE The genetics of Alzheimer-type cognitive decline, dyslipidemia, and diabetes may be the long-sought key that…

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.

Alzforum, 24 Feb 2017

. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.